0
0
9/24/22 at 9:00am
Organization
Fortune
Author
Erin Prater
45 words
0
Comments
One up and coming variant renders society’s last universal COVID antibody drug powerless, experts say. Another variant isn’t far behind it.
You are the first to view
https://fortune.com/well/2022/09/24/new-covid-omicron-variants-subvariants-evade-monoclonal-antibodies-bebtelovimab-recombinants-convergent-evolution-sars-immune-evasion/
Create an account
or login to join the discussion